Neurent Medical Raises €62.5M Funding In Series C Round

The financing was led by MVM Partners, with significant participation from Sofinnova Partners, alongside continued backing from EQT Life Sciences, Atlantic Bridge, Fountain Healthcare Partners and Enterprise Ireland.

Founded in 2015 Neurent Medical focuses on advancing treatments for chronic inflammatory sinonasal diseases. Its flagship NEUROMARK System uses proprietary Impedance Controlled Radiofrequency technology to gently disrupt hyperactive posterior nasal nerves, delivering long-lasting symptom relief for chronic rhinitis with minimal downtime and a strong safety profile.

Read Also - Imperial College London Founders Raise €2.8 M For The Compression Company Satellite data Platform

“I am delighted to welcome MVM Partners and Sofinnova Partners to the Neurent Medical team two global leaders in MedTech investing,” says CEO of Neurent Medical, Brian Shields. “This Series C financing will support our commercial expansion and help bring NEUROMARK to the patients and physicians who need it most.”

According to the company, chronic rhinitis affects millions worldwide, causing persistent symptoms such as nasal congestion, runny nose, sneezing, and postnasal drip, which can significantly impact quality of life.

The NEUROMARK technology targets overactive posterior nasal nerves responsible for these symptoms, offering clinicians a treatment designed to address underlying causes rather than simply manage symptoms.

Neurent Medical has also appointed Kyle Dempsey, Partner at MVM Partners, and Cedric Moreau, Partner at Sofinnova Partners, to its Board of Directors.

“Millions of patients suffer from chronic rhinitis, and posterior nasal nerve ablation represents a powerful tool to provide proven relief,” adds Kyle Dempsey Partner at MVM Partners. “In this rapidly emerging category, Neurent has set a new standard with a best-in-class solution, powered by a proprietary impedance control system that delivers real-time feedback, giving clinicians greater treatment confidence, control, and predictability during every procedure.”

About Neurent Medical

Neurent Medical develops innovative treatments for chronic inflammatory sino-nasal diseases by targeting hyperactive autonomic nerves that drive inflammation. Its NEUROMARK system provides a gentle, in-office treatment for chronic rhinitis, helping reduce persistent symptoms such as nasal congestion and drainage while improving patients’ quality of life.